Enabling Patients with Transthyretin Amyloid Cardiomyopathy to Enroll into Clinical Trials
A shared care model with academic centers can significantly enhance clinical trial enrollment for specialist and complex disease studies.
The recruitment and enrollment of clinical trial patients with specialist and complex diseases can present many challenges.
In this white paper, you will learn about a solution that could increase access to potentially eligible patients with transthyretin amyloid cardiomyopathy, as well as significantly enhance the enrollment time of these patients into clinical trials.
Complete the form to access the white paper.